Page last updated: 2024-08-23

piperacillin and Chemotherapy-Induced Febrile Neutropenia

piperacillin has been researched along with Chemotherapy-Induced Febrile Neutropenia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Álvarez, JC; Cortés, JA; Cuervo, SI; Díaz, JA; Garzón, JR; Gómez, JC; Sánchez, R; Silva, E1
Ali, N; Baqir, M; Hamid, A; Khurshid, M1
Ballanti, S; Bocchia, M; Bucaneve, G; Cantaffa, R; Cascavilla, N; Chierichini, A; Cudillo, L; Del Favero, A; Fabbiano, F; Fanci, R; Ferrari, A; Foà, R; Gentile, G; Luppi, M; Manna, A; Martinelli, G; Martino, B; Micozzi, A; Milone, G; Offidani, M; Picardi, M; Primon, V; Quarta, G; Salutari, P; Specchia, G; Zuffa, E1
Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D1
Miyamura, K; Mori, K; Mukoyama, N; Nakashima, M; Noda, Y; Yoshimi, A1

Trials

3 trial(s) available for piperacillin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Febrile neutropenia: median door-to-needle time - results of an initial audit.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult

2015
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, May-10, Volume: 32, Issue:14

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Chemotherapy-Induced Febrile Neutropenia; Drug Combinations; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Tigecycline; Young Adult

2014
A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins

2017

Other Studies

2 other study(ies) available for piperacillin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy.
    BMC pharmacology & toxicology, 2013, Nov-28, Volume: 14

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Chemotherapy-Induced Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult

2013
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
    Nagoya journal of medical science, 2017, Volume: 79, Issue:1

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cefepime; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Female; Humans; Male; Middle Aged; Piperacillin; Retrospective Studies

2017